In March 25, 2014 Sanford-Burnham Medical Research Institute stated in their publications about a newly created method of placing stem cell-derived pancreatic cells in capsules under the skin that would replace insulin is tested in diabetic disease animal models. The method is successful without producing likely complications. The study confirms the viability of combining stem cells and ‘encapsulation’ technology to treat insulin-dependent diabetes. SugarKiBimari.com does not stand for or against this statement. We would like to shed light on the facts and encourage others to express their thoughts and concerns about the same.
Sanford-Burnham Medical Research Institute (Sanford-Burnham) and UC San Diego School of Medicine scientists have shown that by encapsulating immature pancreatic cells derived from human embryonic stem cells (hESC), and implanting them under the skin in animal models of diabetes, sufficient insulin is produced to maintain glucose levels without unwanted potential trade-offs of the technology. The research suggests that encapsulated hESC-derived insulin-producing cells hold great promise as an effective and safe cell-replacement therapy for insulin-dependent diabetes.
This research is now being noticed and pondered upon in many places around the globe including Nashik India where hopes have been high. But the fact remains that this research has been tested on rats and mice that have much stronger immune systems than humans. One of the main cons in any stem cell therapy is it’s adverse effects on the human immune system and so that concern shall always remain. Will we be able to make this theory into a reality is yet to be concluded.
What do you think?